Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4684-4691

  Guo, Ping ^a   Fang, Quan ^a   Tao, Huo Quan ^a   Schafer, Christopher A ^a   Fenton, Bruce M ^b   Ding, Ivan ^b   Hu, Bo ^a   Cheng, Shi Yuan ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); OVARIECTOMY; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAC OPERON; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASMS, HORMONE-DEPENDENT; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0043136697     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dickson, R. B., Johnson, M. D., el-Ashry, D., Shi, Y. E., Bano, M., Zugmaier, G., Ziff, B., Lippman, M. E., and Chrysogelos, S. Breast cancer: influence of endocrine hormones, growth factors and genetic alterations, Adv. Exp. Med. Biol., 330: 119-141, 1993.
2. Clarke, R., Thompson, E. W., Leonessa, F., Lippman, J., McGarvey, M., Frandsen, T. L., and Brunner, N. Hormone resistance, invasiveness, and metastatic potential in breast cancer. Breast Cancer Res. Treat., 24: 227-239, 1993.
3. Brunner, N., Boulay, V., Fojo, A., Freter, C. E., Lippman, M. E., and Clarke, R. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res., 53: 283-290, 1993.
4. Hyder, S. M., and Stancel, G. M. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol. Endocrinol., 13: 806-811, 1999.
5. Losordo, D. W., and Isner, J. M. Estrogen and angiogenesis: a review. Arterioscler. Thromb. Vasc. Biol., 21: 6-12, 2001.
6. Hyder, S. M., Nawaz, Z., Chiappetta, C., and Stancel, G. M. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res., 60: 3183-3190, 2000.
7. Mueller, M. D., Vigne, J. L., Minchenko, A., Lebovic, D. I., Leitman, D. C., and Taylor, R. N. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β, Proc. Natl. Acad. Sci. USA, 97: 10972-7, 2000.
8. Buteau-Lozano, H., Ancelin, M., Lardeux, B., Milanini, J., and Perrot-Applanat, M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res., 62: 4977-4984, 2002.
9. Ferrara, N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol., 237: 1-30, 1999.
10. Miralem, T., Steinberg, R., Price, D., and Avraham, H. VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells. Oncogene, 20: 5511-5524, 2001.
11. Bachelder, R. E., Crago, A., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G., and Mercurio, A. M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res., 61: 5736-5740, 2001.
12. Bachelder, R. E., Wendt, M. A., and Mercurio, A. M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res., 62: 7203-7206, 2002.
13. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell, 92: 735-745, 1998.
14. Cheng, S-Y., Nagane, M., Su Huang, H-J., and Cavenee, W. K. Intracerebral tumor-associated hemorrhage caused by overexpression of vascular endothelial growth factor (VEGF) isoforms, VEGF121 and VEGF 165 but not VEGF189. Proc. Natl. Acad. Sci. USA, 94: 12081-12087, 1997.
15. Zhang, L., Kharbanda, S., Chen, D., Bullocks, J., Miller, D. L., Ding, I. Y., Hanfelt, J., McLeskey, S. W., and Kern, F. G. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene, 15: 2093-108, 1997.
16. Guo, P., Xu, L., Pan, S., Brekken, R. A., Yang, S. T., Whitaker, G. B., Nagane, M., Thorpe, P. E., Rosenbaum, J. S., Su Huang, H. J., Cavenee, W. K., and Cheng, S. Y. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res., 61: 8569-8577, 2001.
17. Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H. J., Cavenee, W. K., and Cheng, S. Y. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am. J. Pathol., 162: 1083-1093, 2003.
18. Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., and Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res., 47: 4355-4360, 1987.
19. McLeskey, S. W., Kurebayashi, J., Honig, S. F., Zwiebel, J., Lippman, M. E., Dickson, R. B., and Kern, F. G. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res., 53: 2168-2177, 1993.
20. Smith, L. M., Wise, S. C., Hendricks, D. T., Sabichi, A. L., Bos, T., Reddy, P., Brown, P. H., and Birrer, M. J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene, 18: 6063-6070, 1999.
21. Vickers, P. J., Dickson, R. B., Shoemaker, R., and Cowan, K. H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol., 2: 886-892, 1988.
22. Sledge, G. W., Jr. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects, Semin. Oncol., 29: 104-110, 2002.
23. Zhang, H. T., Scott, P. A., Morbidelli, L., Peak, S., Moore, J., Turley, H., Harris, A. L., Ziche, M., and Bicknell, R. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br. J. Cancer, 83: 63-68, 2000.
24. McLeskey, S. W., Tobias, C. A., Vezza, P. R., Filie, A. C., Kern, F. G., and Hanfelt, J. Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. Am. J. Pathol., 153: 1993-2006, 1998.
25. Xie, B., Tam, N. N., Tsao, S. W., and Wong, Y. C. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat. Br. J. Cancer, 81: 1335-1343, 1999.
26. Pedram, A., Razandi, M., and Levin, E. R. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J. Biol. Chem., 273: 26722-26728, 1998.
27. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., and Koh, G. Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E- selectin through nuclear factor-κ B activation in endothelial cells. J. Biol. Chem., 276: 7614-7620, 2001.
28. Gerber, H. P., Dixit, V., and Ferrara, N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem., 273: 13313-13316, 1998.
29. 1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem., 272: 10882-10894, 1997.
30. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997.
31. Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., and Safe, S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J. Biol. Chem., 274: 32099-32107, 1999.
32. Dickson, R. B., McManaway, M. E., and Lippman, M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science (Wash. DC), 232: 1540-1543, 1986.